R Huerta-Gutiérrez1, L Braga2, A Camacho-Ortiz3, Humberto Díaz-Ponce4, L García-Mollinedo5, M Guzmán-Blanco6, S Valderrama-Beltrán7, E Landaeta-Nezer8, S Moreno-Espinosa9, Rayo Morfín-Otero10, P Rodríguez-Zulueta11, A Rosado-Buzzo12, Fernando Rosso-Suárez13, W Trindade-Clemente14, Denusa Wiltgen15. 1. Instituto Nacional de Salud Pública (INSP), Tlalpan, CDMX, Mexico. 2. CCIH-HC/UFMG Filial Ebserh, Brazil. 3. Infectious Deseases, Department Hospital Universitario Dr. José E. González, Monterrey, N.L., Mexico. 4. Links and Links External Consultant for Latin America. 5. FAC MED UNAM Departamento ICB-DICIM, Mexico. 6. Jefe del Departamento de Medicina del Centro Médico y Jefe de Servicio de Infectología del Hospital Vargas, Caracas, Venezuela. 7. Jefe de Unidad de Infectología, Hospital Universitario San Ignacio, Pontífica Universidad Javeriana, Colombia. 8. Jefe de Servicio de Infectología del Hospital Universitario de Caracas, Caracas, Distrito Capital, Venezuela. 9. Departamento de Infectología del Hospital Infantil de México, "Federico Gómez", Mexico. 10. Hospital Civil de Guadalajara "Fray Antonio Alcalde", Instituto de Patología Infecciosa, Universidad de Guadalajara, Mexico. 11. Department of Infectious Diseases, Hospital General Dr. Manuel GEA González, Mexico City, Mexico. 12. Links&Links Tlalpan, CDMX, Mexico. Electronic address: alfonso.rosado@linksandlinks.com.mx. 13. Departamento de Medicina Interna-Infectología, Fundación Clínica Valle del Lili, Cali, Colombia. 14. Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil. 15. Universidade Federal de Ciências da Saúde de Porto AlegreRio Grande do Sul, Brazil.
Abstract
BACKGROUND AND AIMS: Experience in the region shows that in some countries there is very good surveillance of Healthcare-associated infections (HAIs) in health services, but there is no national data consistently in all countries. Therefore, we set to estimate the total burden of HAIs and antimicrobial use in acute care hospitals in Brazil, Venezuela, Mexico, and Colombia using the one-day point prevalence methodology. METHODS: The survey was conducted between June and July 2016. In each ward or unit, HAIs and antimicrobial use data were collected on a single day by a trained team of researchers. Also, for each patient, we collected data on risk factors for infections. RESULTS: One out of ten individuals surveyed had at least one healthcare-associated infection (HAI). Pneumonia and surgical site infections were the most relevant among the surveyed countries. Most of the surveyed participants, regardless of their HAI status, received antibiotics except the individuals managed in Brazil. Carbapenems and third-generation Cephalosporins were among the most frequently used antibiotics. CONCLUSION: Our results add to WHO's recent efforts to understand HAIs prevalence and antibiotic consumption in low and middle-income countries, of which we studied three that were not included in their last report.
BACKGROUND AND AIMS: Experience in the region shows that in some countries there is very good surveillance of Healthcare-associated infections (HAIs) in health services, but there is no national data consistently in all countries. Therefore, we set to estimate the total burden of HAIs and antimicrobial use in acute care hospitals in Brazil, Venezuela, Mexico, and Colombia using the one-day point prevalence methodology. METHODS: The survey was conducted between June and July 2016. In each ward or unit, HAIs and antimicrobial use data were collected on a single day by a trained team of researchers. Also, for each patient, we collected data on risk factors for infections. RESULTS: One out of ten individuals surveyed had at least one healthcare-associated infection (HAI). Pneumonia and surgical site infections were the most relevant among the surveyed countries. Most of the surveyed participants, regardless of their HAI status, received antibiotics except the individuals managed in Brazil. Carbapenems and third-generation Cephalosporins were among the most frequently used antibiotics. CONCLUSION: Our results add to WHO's recent efforts to understand HAIs prevalence and antibiotic consumption in low and middle-income countries, of which we studied three that were not included in their last report.
Authors: Win Thandar Oo; Samuel D Carr; Christian S Marchello; Moe Moe San; Aung Tun Oo; Khine Mar Oo; Kay Thi Lwin; Hla Hla Win; John A Crump Journal: Infect Prev Pract Date: 2021-12-11
Authors: Federico A Zumaya-Estrada; Alfredo Ponce-de-León-Garduño; Edgar Ortiz-Brizuela; Juan Carlos Tinoco-Favila; Patricia Cornejo-Juárez; Diana Vilar-Compte; Alejandro Sassoé-González; Pedro Jesus Saturno-Hernandez; Celia M Alpuche-Aranda Journal: Infect Drug Resist Date: 2021-11-02 Impact factor: 4.003
Authors: M J Loftus; S J Curtis; R Naidu; A C Cheng; A W J Jenney; B G Mitchell; P L Russo; E Rafai; A Y Peleg; A J Stewardson Journal: Antimicrob Resist Infect Control Date: 2020-08-28 Impact factor: 4.887